通用名称为ASCOMP瓦特可待因
磷酸可待因30毫克，布他比妥50毫克，阿司匹林325mg，咖啡因40毫克;上限。

法律分类：
CIII

药理班级ASCOMP瓦特可待因
阿片类药物+巴比妥+水杨酸+兴奋剂。

制造商ASCOMP W。可待因
布雷肯里奇制药公司
主治为ASCOMP瓦特可待因
张力（或肌肉收缩）头痛。

成人剂量为ASCOMP W。可待因
1-2帽每4小时，根据需要，最大6帽/天。使用最短的时间内最低的有效剂量。

儿童剂量为ASCOMP瓦特可待因
不推荐。

禁忌的ASCOMP瓦特可待因
类固醇消炎药过敏。卟啉症。出血或凝血功能障碍。消化性溃疡。

警告/注意事项为ASCOMP W。可待因
肾或肝功能不全;监测肝/肾功能检查。急腹症。哮喘。出血性疾病。头部受伤。颅内压增高。甲状腺或肾上腺皮质功能受损。 GI或顾阻塞。可待因超快速代谢（可能会遇到过量症状）。药物滥用者。老人。虚弱。劳动和交付。妊娠（Cat.C）。哺乳母亲：不推荐。

相互作用的ASCOMP瓦特可待因
中枢神经系统的影响可能增强了单胺氧化抑制剂。随之而来的皮质类固醇激素：皮质类固醇撤离可能会导致salicylism。口服抗凝血剂可能使可能，口服抗糖尿病药物和胰岛素，6 - 巯基嘌呤和甲氨蝶呤，NSAIDs的，其他麻醉止痛剂，酒精，一般麻醉剂，镇静剂，镇静安眠药，镇静剂等中枢神经系统。可能会削弱对uricosuric药物的效果。

为ASCOMP W.不良反应可待因
嗜睡，头晕，陶醉感，胃肠不适/疼痛。

如何ASCOMP瓦特可待因提供？
帽子 - 100，500

DESCRIPTION ASCOMP® with Codeine (Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP) is supplied in capsule form for oral administration. Each capsule contains the following active ingredients: Butalbital, USP ..................................................................................... 50 mg Aspirin, USP ....................................................................................... 325 mg Caffeine, USP ....................................................................................... 40 mg Codeine Phosphate, USP ...................................................................... 30 mg

ASCOMP w. CODEINE

Generic Name for ASCOMP w. CODEINE Codeine phosphate 30mg, butalbital 50mg, aspirin 325mg, caffeine 40mg; caps. Legal Classification: CIII Pharmacological Class for ASCOMP w. CODEINE Opioid + barbiturate + salicylate + stimulant. Manufacturer of ASCOMP w. CODEINE Breckenridge Pharmaceutical, Inc. Indications for ASCOMP w. CODEINE Tension (or muscle contraction) headache. Adult dose for ASCOMP w. CODEINE 1–2 caps every 4 hours, as needed; max 6 caps/day. Use lowest effective dose for shortest period of time. Children's dosing for ASCOMP w. CODEINE Not recommended. Contraindications for ASCOMP w. CODEINE NSAID allergy. Porphyria. Bleeding or coagulation disorders. Peptic ulcer. Warnings/Precautions for ASCOMP w. CODEINE Renal or hepatic impairment; monitor liver/renal function tests. Acute abdomen. Asthma. Bleeding disorders. Head injury. Increased intracranial pressure. Impaired thyroid or adrenocortical function. GI or GU obstruction. Ultra-rapid metabolizers of codeine (may experience overdose symptoms). Drug abusers. Elderly. Debilitated. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended. Interactions for ASCOMP w. CODEINE CNS effects may be enhanced by MAOIs. Concomitant corticosteroids: withdrawal of corticosteroid may result in salicylism. May potentiate oral anticoagulants, oral antidiabetics and insulin, 6-mercaptopurine and methotrexate, NSAIDs, other narcotic analgesics, alcohol, general anesthetics, tranquilizers, sedative-hypnotics, other CNS depressants. May diminish effects of uricosuric agents. Adverse Reactions for ASCOMP w. CODEINE Drowsiness, dizziness, intoxicated feeling, GI upset/pain. How is ASCOMP w. CODEINE supplied? Caps—100, 500